StockNews.com Initiates Coverage on Phibro Animal Health (NASDAQ:PAHC)

StockNews.com assumed coverage on shares of Phibro Animal Health (NASDAQ:PAHC – Get Rating) in a report released on Thursday morning. The firm issued a hold rating on the stock.

Several other equities analysts also recently issued reports on PAHC. Morgan Stanley cut their price objective on Phibro Animal Health from $20.00 to $19.00 and set an equal weight rating for the company in a research report on Thursday, February 9th. Roth Capital began coverage on Phibro Animal Health in a research report on Wednesday, December 21st. They set a buy rating and a $18.00 target price for the company. One equities research analyst has rated the stock with a sell rating, two have issued a hold rating and one has assigned a buy rating to the stock. Based on data from MarketBeat.com, Phibro Animal Health currently has an average rating of Hold and a consensus target price of $18.00.

Phibro Animal Health Trading Down 4.0 %

Shares of PAHC opened at $14.52 on Thursday. The stock has a fifty day moving average price of $15.49 and a two-hundred day moving average price of $14.27. The company has a debt-to-equity ratio of 1.72, a quick ratio of 1.75 and a current ratio of 3.47. Phibro Animal Health has a 52-week low of $11.75 and a 52-week high of $20.68. The company has a market cap of $588.06 million, a price-to-earnings ratio of 16.13, a PEG ratio of 8.10 and a beta of 0.60.

Phibro Animal Health (NASDAQ:PAHC – Get Rating) last issued its quarterly earnings data on Wednesday, February 8th. The company reported $0.34 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.30 by $0.04. Phibro Animal Health had a return on equity of 18.90% and a net margin of 3.73%. The firm had revenue of $244.60 million during the quarter, compared to the consensus estimate of $238.44 million. Analysts predict that Phibro Animal Health will post 1.25 EPS for the current fiscal year.

Phibro Animal Health Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Wednesday, March 22nd. Stockholders of record on Wednesday, March 1st will be given a dividend of $0.12 per share. The ex-dividend date of this dividend is Tuesday, February 28th. This represents a $0.48 dividend on an annualized basis and a dividend yield of 3.31%. Phibro Animal Health’s payout ratio is currently 53.33%.

Institutional Investors Weigh In On Phibro Animal Health

Institutional investors and hedge funds have recently made changes to their positions in the company. Gladius Capital Management LP grew its stake in shares of Phibro Animal Health by 25.8% during the fourth quarter. Gladius Capital Management LP now owns 3,088 shares of the company’s stock worth $42,000 after purchasing an additional 634 shares during the period. Legal & General Group Plc grew its stake in shares of Phibro Animal Health by 1.5% during the fourth quarter. Legal & General Group Plc now owns 50,388 shares of the company’s stock worth $676,000 after purchasing an additional 756 shares during the period. First Republic Investment Management Inc. grew its stake in shares of Phibro Animal Health by 6.7% during the second quarter. First Republic Investment Management Inc. now owns 13,276 shares of the company’s stock worth $254,000 after purchasing an additional 836 shares during the period. Principal Financial Group Inc. grew its stake in shares of Phibro Animal Health by 0.7% during the fourth quarter. Principal Financial Group Inc. now owns 131,202 shares of the company’s stock worth $1,759,000 after purchasing an additional 924 shares during the period. Finally, Martingale Asset Management L P grew its stake in shares of Phibro Animal Health by 3.4% during the second quarter. Martingale Asset Management L P now owns 30,640 shares of the company’s stock worth $587,000 after purchasing an additional 1,017 shares during the period. Institutional investors own 49.21% of the company’s stock.

About Phibro Animal Health

(Get Rating)

Phibro Animal Health Corp. engages in the manufacture and supply of animal health and mineral nutrition products. It operates through the following segments: Animal Health, Mineral Nutrition, and Performance Products. The Animal Health segment develops and markets antibacterial, nutritional specialty products, and vaccines.